United States
Germany
Japan
United Kingdom
China
TYRO3 mouse monoclonal antibody, clone OTI4C8 (formerly 4C8)
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
GBE1 mouse monoclonal antibody, clone OTI3B4 (formerly 3B4)
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-SLC7A8 (LAT2) mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 800.00
现货
Anti-LTA4H (Leukotriene A4 hydrolase) mouse monoclonal antibody, clone OTI8F4 (formerly 8F4)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Mouse |
Anti-LEMD3 (MAN1) mouse monoclonal antibody, clone OTI6C10 (formerly 6C10)
| Applications | IP, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
GBE1 mouse monoclonal antibody, clone OTI4D9 (formerly 4D9)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-PLK1 mouse monoclonal antibody, clone OTI8C12 (formerly 8C12)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Target Symbol
Knockout (KO) Validation
Isotypes
Clonalities
Families
Pathways
- Metabolic pathways (14)
- Starch and sucrose metabolism (7)
- Adherens junction (6)
- Chemokine signaling pathway (6)
- Chronic myeloid leukemia (6)
- ErbB signaling pathway (6)
- Focal adhesion (6)
- Glioma (6)
- Insulin signaling pathway (6)
- MAPK signaling pathway (6)
- Natural killer cell mediated cytotoxicity (6)
- Neurotrophin signaling pathway (6)
- Oocyte meiosis (6)
- Pathways in cancer (6)
- Progesterone-mediated oocyte maturation (6)
- Regulation of actin cytoskeleton (6)
- Acute myeloid leukemia (5)
- Axon guidance (5)
- Bladder cancer (5)
- Pancreatic cancer (5)
- Alzheimer's disease (4)
- Arachidonic acid metabolism (4)
- B cell receptor signaling pathway (4)
- Cell cycle (4)
- Colorectal cancer (4)
- Dorso-ventral axis formation (4)
- Endometrial cancer (4)
- Fc epsilon RI signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- Gap junction (4)
- GnRH signaling pathway (4)
- Long-term depression (4)
- Long-term potentiation (4)
- Melanogenesis (4)
- Melanoma (4)
- NOD-like receptor signaling pathway (4)
- Non-small cell lung cancer (4)
- Prion diseases (4)
- Prostate cancer (4)
- Renal cell carcinoma (4)
- T cell receptor signaling pathway (4)
- TGF-beta signaling pathway (4)
- Thyroid cancer (4)
- Toll-like receptor signaling pathway (4)
- Type II diabetes mellitus (4)
- VEGF signaling pathway (4)
- Vascular smooth muscle contraction (4)
- mTOR signaling pathway (4)
- Cysteine and methionine metabolism (3)
- Glycolysis / Gluconeogenesis (3)
- Propanoate metabolism (3)
- Pyruvate metabolism (3)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Dilated cardiomyopathy (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Leukocyte transendothelial migration (2)
- Pathogenic Escherichia coli infection (2)
- Systemic lupus erythematosus (2)
- Tight junction (2)
- Vibrio cholerae infection (2)
- Viral myocarditis (2)
- p53 signaling pathway (2)
- Cell adhesion molecules (CAMs) (1)
- DNA replication (1)
- Homologous recombination (1)
- Mismatch repair (1)
- Nucleotide excision repair (1)
